Vita Life Sciences : Application for quotation of securities - VLS

Announcement Summary

Entity name

VITA LIFE SCIENCES LIMITED..

Announcement Type

New announcement

Date of this announcement

Wednesday April 20, 2022

The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

Total number of +securities to be quoted

ASX +security

Number of +securities to
code	Security description	Issue date
VLS	ORDINARY FULLY PAID	485,000	20/04/2022

be quoted

Refer to next page for full details of the announcementPart 1 - Entity and announcement details

1.1 Name of entity

VITA LIFE SCIENCES LIMITED..

We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules.

1.2 Registered number type ABN

1.3 ASX issuer code VLS

1.4 The announcement isNew announcement

1.5 Date of this announcement 20/4/2022

Registration number 35003190421

Part 2 - Type of Issue

2.1 The +securities to be quoted are:

+Securities issued, transferred or re-classified as a result of options being exercised or other +convertible securities being converted

2.2 The +securities to be quoted are:

Additional +securities in a class that is already quoted on ASX ("existing class")

Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B

Existing +securities converting into additional +securities in an existing class

FROM (Existing Class)

ASX +security code and description

VLSAC : PERFORMANCE SHARES

TO (Existing Class)

ASX +security code and description

VLS : ORDINARY FULLY PAID

Please state the number of options	The first date the options were	The last date the options were
that were exercised or other	exercised or other +convertible	exercised or other +convertible
+convertible securities that were	securities were converted	securities were converted
converted
20/4/2022	30/6/2022
485,000

Is this all of the options or other +convertible securities on issue of that type (ie have all of those options now been exercised or have all of those convertible securities now been converted)?

No

The right of the holder of the options or other +convertible securities to receive the +underlying securities is being satisfied by:

A reclassification of the +convertible securities as securities in the same class as the +underlying securities

The underlying securities being received by the holder are:

Intended to be, but are not yet, quoted by ASX

Were the options being exercised or other +convertible securities being converted issued under an +employee incentive scheme?

Yes

Are any of the options being exercised or other +convertible securities being converted held by +key management personnel (KMP) or an +associate?

Yes

Provide details of the KMP or +associates who are exercising options or converting convertible securities

Number of options being exercised or other +convertible securitiesName of KMP

Name of registered holder

being converted

Melissa Pereira

Melissa Pereira 75,000

June Lau

June Lau 40,000

K S Beh

K S Beh 40,000

Chin L Khoo

Chin L Khoo 80,000

Henry Townsing

Henry Townsing

250,000

only

Issue date 20/4/2022

Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class?

Yes

For personal use

Issue details

Number of +securities to be quoted 485,000

Are the +securities being issued for a cash consideration?

Yes

In what currency is the cash consideration being paid?

AUD - Australian Dollar

What is the issue price per +security?

AUD 1.20000000

Any other information the entity wishes to provide about the +securities to be quoted

Shares issued previously as per ASX announcement dated 30 June 2021 (under VLSAC code), now exercised as performance hurdles were achieved (under VLS code).